Journal of Clinical Oncology

Vol. 44, Issue 16_suppl Issue 16_suppl 2026
7213
Articles

Articles in this Issue

Multi-study genomic survival modeling and gene panel recalibration across heterogeneous cohorts.

Zheng Qu, Hongzhe Zhang, Yi Fang Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13671

e13671 Background: Gene expression–based prognostic models and multigene panels are widely used for risk stratification in...

Diagnostic and predictive utility of peritoneal tumor DNA in gastroesophageal cancer: A prospective multicenter study.

David Liu, Yuxuan Wang, Zexi Allan et al. Jun 01, 2026 pp. 4101-4101 10.1200/jco.2026.44.16_suppl.4101

4101 Background: Gastric and gastroesophageal cancers (G/GEC) commonly spread to the peritoneum. Accurate peritoneal stagi...

Tumor microenvironment phenotypes and survival in fibrolamellar carcinoma: An exploratory study.

Hilal Polat, Paul Kent, Tom Michael Stockwell et al. Jun 01, 2026 pp. 4150-4150 10.1200/jco.2026.44.16_suppl.4150

4150 Background: Fibrolamellar carcinoma (FLC) is a very rare liver cancer affecting children, adolescents, and young adul...

Safety, immunogenicity, and efficacy of Ad5.F35-GUCY2C-PADRE vaccine in patients with GI cancers at high risk of relapse: Results from a phase 2A trial.

Babar Bashir, Zhengyang Sun, Jagmohan Singh et al. Jun 01, 2026 pp. 3617-3617 10.1200/jco.2026.44.16_suppl.3617

3617 Background: Guanylyl cyclase C (GUCY2C) is an intestinal tumor antigen ectopically expressed in some gastroesophageal...

Rural-urban disparities in demographics, clinical characteristics, and hospitalization burden among young non-smoking adults with lung cancer in the United States.

Rahul Singla, Aishwarya Ramesh, Fathima Shehnaz Ayoobkhan et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20645

e20645 Background: Recent reports indicate a rise in lung cancer incidence among young non-smokers, yet rural-urban differ...

Evaluating trust in health information sources among persons with a cancer diagnosis: An analysis of the HINTS database.

Uchenna Chukwuemeka Nkwonta, Mawulorm Kwaku Denu, Geraldine Kordai Mould et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23342

e23342 Background: Trust in health information sources plays a critical role in how patients understand and adhere to thei...

Emiltatug ledadotin (Emi-Le), a B7-H4–directed antibody-drug conjugate (ADC), in patients with aggressive adenoid cystic carcinoma (ACC): Phase 1 interim analysis.

Glenn J. Hanna, Guilherme Rabinowits, Shirin Attarian et al. Jun 01, 2026 pp. 6010-6010 10.1200/jco.2026.44.16_suppl.6010

6010 Background: ACC is a rare cancer that typically arises in the salivary glands but can affect various organs. About 40...

Real-world comparison of remission status in newly diagnosed multiple myeloma treated with daratumumab-based versus bortezomib-based first-line therapy.

Chander Perkash Khatri, Madho Mal, Jennifer Calafato Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e19572

e19572 Background: The introduction of CD38 monoclonal antibodies has transformed the frontline management of newly diagno...

Direct oral anticoagulants versus low-molecular-weight heparin for venous thromboembolism in primary brain tumors: A TriNetX real-world analysis.

Medina Esenbekova, Daria Chelysheva, Benjamin Hanson et al. Jun 01, 2026 pp. 2054-2054 10.1200/jco.2026.44.16_suppl.2054

2054 Background: Venous thromboembolism (VTE) is a common complication in patients with primary brain tumors and is associ...

Thrombotic events in patients receiving immune checkpoint inhibitors: Incidence, risk factors, and prognostic outcomes from a retrospective cohort study.

Ali Awada, Ali Ghais, Sary Faraj et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e24155

e24155 Background: Immune checkpoint inhibitors (ICIs) have transformed cancer outcomes across multiple malignancies. Howe...

Comparative evaluation of the diagnostic value of microRNAs for early colorectal cancer detection in adults: Results of a systematic review and network meta-analysis.

Evgenii Grivachev, Mikhail Fedyanin, Alexey Tryakin et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15530

e15530 Background: Circulating microRNAs (miRNAs) are promising non-invasive biomarkers for colorectal cancer (CRC), but t...

Prediction of pathologic response using a taxane-based gene expression signature in RNA-sequencing data from breast cancer patients receiving neoadjuvant therapy.

Jan Nart, Beatrice Hahn, Jacob Niklassen et al. Jun 01, 2026 pp. 549-549 10.1200/jco.2026.44.16_suppl.549

549 Background: Taxanes are frequently used in both early and advanced breast cancer, but their use has not yet been guide...

Survival and socioeconomic disparities in the elderly population with mycosis fungoides and Sézary syndrome: A comparative analysis of 2,690 patients by facility type.

Oscar Hinojosa, Juan Ospina, Joel Michalek et al. Jun 01, 2026 pp. 7069-7069 10.1200/jco.2026.44.16_suppl.7069

7069 Background: Mycosis fungoides (MF) and Sézary syndrome (SS) are rare T-cell malignancies (0.26 and 0.36/100,000 perso...

Revumenib as maintenance for AML following allogeneic stem cell transplantation.

Hannah Goulart, Olayinka Okeleji, Courtney Denton DiNardo et al. Jun 01, 2026 pp. 6505-6505 10.1200/jco.2026.44.16_suppl.6505

6505 Background: Relapse after allogeneic stem cell transplantation (SCT) remains common in acute myeloid leukemia (AML)....

Systemic antibiotic exposure and outcomes of immune checkpoint inhibitors in non–small cell lung cancer.

Giuliana Ciappina, Enrica Toscano, Patrizia Carroccio et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20602

e20602 Background: Immune checkpoint inhibitors (ICIs) have transformed the management of solid tumors, particularly non–s...

Phase II open-label trial of neoadjuvant immunotherapy in combination with CAPOX for resectable non-metastatic proficient mismatch repair (pMMR) colon cancer: NICER study.

Atif Iqbal, Shalini Makawita, Hector Garcia-Chavez et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.tps2691

TPS2691 Background: Colorectal cancer (CRC) is the third most common malignancy worldwide. Immune checkpoint inhibition ha...

Association of baseline protein–energy malnutrition with mortality and healthcare utilization in patients with hepatocellular carcinoma treated with VEGF-based systemic therapy.

Nandhini Iyer, Ansy Patel, Diana Franco et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e16166

e16166 Background: Patients with hepatocellular carcinoma (HCC) frequently have advanced liver disease and frailty at the...

QUINTESSENTIAL-2: A phase 3 study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide.

Eyal Lebel, Ahmed Abdulgawad, Stefania Bramanti et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.tps7577

TPS7577 Background: Despite advances in multiple myeloma (MM) treatment, most patients (pts) will relapse, highlighting th...

Prevalence of post-traumatic stress disorder and associated factors among adult sarcoma patients.

Sang Minh Nguyen, Douglas DeMoulin, Michael J. Robinson et al. Jun 01, 2026 pp. 11557-11557 10.1200/jco.2026.44.16_suppl.11557

11557 Background: A cancer diagnosis and treatment can be extremely stressful and even traumatic for sarcoma patients. How...

Immune checkpoint inhibitor adoption, timing, and survival in an urban lung cancer cohort: A landmark analysis.

Palak Dutta, Apurva Mallisetty, Erin Weisser et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20697

e20697 Background: Although immune checkpoint inhibitors (ICIs) improve survival in randomized trials, real-world use is s...

Disproportionate reporting of severe gastrointestinal injury with ruxolitinib among JAK inhibitors in myeloproliferative neoplasms: A FAERS pharmacovigilance analysis.

Sufian Sorathia, Aqsa Zoey Sorathia Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e18600

e18600 Background: Janus kinase (JAK) inhibitors are cornerstone therapies for myeloproliferative neoplasms (MPNs). Althou...

Burden and trends of cancer and attributable risk factors in women, 1990 to 2023, with projections of mortality to 2050.

Tapan Ramesh Giri, Kofi Boakye Opoku, Kwame Adjei Sefah et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e22624

e22624 Background: Cancer (CA) is a leading cause of premature mortality and disability in women worldwide. Women specific...

Detection, quantification, and subtyping of adenoid cystic carcinoma (ACC) using methylation from liquid biopsies.

Felippe Lazar Neto, Omnia Abdelmoneim Khidir Ahmed, Camilla Oliveira Hoff et al. Jun 01, 2026 pp. 6118-6118 10.1200/jco.2026.44.16_suppl.6118

6118 Background: Despite the common indolent behavior of ACC, some patients will experience aggressive disease with short...

Implementation of a multi-cancer early detection (MCED) test in a private practice: Adoption, performance, and repeat-testing patterns.

Eric Sue, Aaron Chiang, David Kanani et al. Jun 01, 2026 pp. 10532-10532 10.1200/jco.2026.44.16_suppl.10532

10532 Background: Century City Medical Management (CCMM), a network of private primary care practices, implemented MCED te...

Lung cancer navigation pilot: Preliminary results of nurse outreach support for lung cancer patients enrolled in the EOM.

Terry Lynn Jensen, Susan Marie Escudier, Holly Books et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13580

e13580 Background: Oncology practices struggle with reducing unnecessary ED visits and hospitalizations. This is an import...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page